孙静, 杜玄一. 慢性肾脏病高钾血症发病机制及治疗进展[J]. 实用临床医药杂志, 2021, 25(5): 125-128. DOI: 10.7619/jcmp.20201152
引用本文: 孙静, 杜玄一. 慢性肾脏病高钾血症发病机制及治疗进展[J]. 实用临床医药杂志, 2021, 25(5): 125-128. DOI: 10.7619/jcmp.20201152
SUN Jing, DU Xuanyi. Research progress in pathogenesis and treatment of hyperkalemia in chronic kidney disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 125-128. DOI: 10.7619/jcmp.20201152
Citation: SUN Jing, DU Xuanyi. Research progress in pathogenesis and treatment of hyperkalemia in chronic kidney disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 125-128. DOI: 10.7619/jcmp.20201152

慢性肾脏病高钾血症发病机制及治疗进展

Research progress in pathogenesis and treatment of hyperkalemia in chronic kidney disease

  • 摘要: 高钾血症是慢性肾脏病常见的并发症,轻度的高钾血症会影响神经-肌肉系统的兴奋性,导致患者出现心律失常、肌无力、酸中毒等临床表现;重度的高钾血症会引起心脏骤停、呼吸衰竭等严重并发症。本研究对慢性肾脏病高钾血症的发病机制、危害、治疗现状及进展进行综述。

     

    Abstract: hyperkalemia is a common complication of chronic kidney disease.Mild hyperkalemia can affect the excitability of neuromuscular system and induce arrhythmia, myasthenia, acidosis and other clinical manifestations.Severe hyperkalemia can cause cardiac arrest, respiratory failure and other severe complications.This study reviewed the pathogenesis, damage, treatment status and progress of hyperkalemia in chronic kidney disease.

     

/

返回文章
返回